AIMS Medical has been awarded the prestigious Neotec 2023 grant, granted by the Centre for the Development of Industrial Technology (CDTI), with funding of €325.000. This support is a key boost to further develop our technology that allows health professionals to know the risk of oropharyngeal dysphagia to improve patient care and reduce health system costs.
Thanks to Neotec’s support, we will advance in the development and implementation of our AIMS-OD solutions (already clinically validated in more than 9,000 patients), and in the new AIMS-MN (malnutrition) and AIMS-AP (aspiration pneumonia) lines. This project will also allow us to strengthen our team with the incorporation of new specialised profiles, including a doctor.
The Neotec support represents a further step in the consolidation of AIMS Medical as a benchmark in the development of artificial intelligence solutions applied to healthcare, and brings us closer to our goal: to improve the quality of life of patients.
